Celon Pharma S.A. (WSE:CLN)
20.75
-0.15 (-0.72%)
Aug 14, 2026, 5:00 PM CET
Celon Pharma Market Cap
Celon Pharma has a market cap or net worth of 1.12 billion as of August 14, 2026. Its market cap has decreased by -10.17% in one year.
Market Cap
1.12B
Enterprise Value
1.16B
Revenue
254.41M
Ranking
n/a
PE Ratio
10.18
Stock Price
20.75
ChartMarket Cap Chart
Since December 1, 2016, Celon Pharma's market cap has increased from 1.00B to 1.12B, an increase of 11.46%. That is a compound annual growth rate of 1.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 1.12B | 1.97% |
| Dec 30, 2025 | 1.10B | -23.06% |
| Dec 30, 2024 | 1.42B | 80.47% |
| Dec 29, 2023 | 789.33M | 10.32% |
| Dec 30, 2022 | 715.51M | -57.68% |
| Dec 30, 2021 | 1.69B | -7.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.70B |
| NEUCA | 3.49B |
| Synektik Spólka Akcyjna | 3.07B |
| Voxel | 1.35B |
| Medinice | 652.85M |
| Syn2bio | 575.25M |
| Centrum Medyczne ENEL-MED | 562.78M |
| Selvita | 523.13M |